GlassScriptPhysician profile
Brian P Feehan
NPI 1457513319
$1,619.53
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $493 · 2021: $370 · 2022: $13.92 · 2023: $84.72 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $397.47 | 2019-2021 | |
| Amgen INC. | $260.40 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $206.35 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $127.70 | 2020-2021 | |
| Medtronic Vascular, INC. | $117.82 | 2019 | |
| Novo Nordisk INC | $100.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $83.92 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $64.71 | 2020-2023 | Varithena Administration Pack |
| Arbor Pharmaceuticals, INC. | $49.41 | 2019-2020 | |
| Gilead Sciences, INC. | $30.00 | 2019 | |
| Medtronic, INC. | $28.63 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $27.54 | 2019 | |
| Medtronic Minimed, INC. | $15.00 | 2019 | |
| Lilly USA, LLC | $15.00 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.80 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.06 | 2021 | |
| Pfizer INC. | $13.75 | 2020 | |
| Astellas Pharma US INC | $13.44 | 2020 | |
| Abbvie INC. | $12.51 | 2020 | |
| Daiichi Sankyo INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Feehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.